Complement receptor 1 (A3650G RsaI and Intron 27 HindIII) polymorphisms and risk of gallbladder cancer in North Indian population

Scandinavian Journal of Immunology

Volumn 70, Issue 6, 2009, Pages 614-620

  Srivastava, A ^a   Mittal, B ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C3B RECEPTOR;

ADULT; AGED; ALLELE; ARTICLE; CANCER RISK; CHOLELITHIASIS; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; GALLBLADDER CANCER; GENDER; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HUMAN; HUMAN CELL; HUMAN TISSUE; INDIAN; INTRON; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; POPULATION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

ADULT; ALLELES; CASE-CONTROL STUDIES; FEMALE; GALLBLADDER NEOPLASMS; GALLSTONES; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; INDIA; INTRONS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RECEPTORS, COMPLEMENT; SEX FACTORS;

EID: 70450105536     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/j.1365-3083.2009.02329.x     Document Type: Article

References (21)

1. Sullivan KE, Jawad AF, Piliero LM et al. Analysis of polymorphisms affecting immune complex handling in systemic lupus erythematosus. Rheumatology (Oxford) 2003 42 : 446 452.
2. Jiao XY, Lu MD, Huang JF, Liang LJ, Shi JS. Genomic determination of CR1 CD35 density polymorphism on erythrocytes of patients with gallbladder carcinoma. World J Gastroenterol 2004 10 : 3480 3484.
3. Cockburn IA, Mackinnon MJ, O'Donnell A et al. A human complement receptor 1 polymorphism that reduces Plasmodium falciparum rosetting confers protection against severe malaria. Proc Natl Acad Sci USA 2004 101 : 272 277.
4. Nagayasu E, Ito M, Akaki M et al. CR1 density polymorphism on erythrocytes of falciparum malaria patients in Thailand. Am J Trop Med Hyg 2001 64 : 1 5.
5. Zorzetto M, Bombieri C, Ferrarotti I et al. Complement receptor 1 gene polymorphisms in sarcoidosis. Am J Respir Cell Mol Biol 2002 27 : 17 23.
6. Herrera AH, Xiang L, Martin SG, Lewis J, Wilson JG. Analysis of complement receptor type 1 (CR1) expression on erythrocytes and of CR1 allelic markers in Caucasian and African American populations. Clin Immunol Immunopathol 1998 87 : 176 183.
7. Albores-Saavedra J, de Jesus Manrique J, Angeles-Angeles A, Henson DE. Carcinoma in situ of the gallbladder. A clinicopathologic study of 18 cases. Am J Surg Pathol 1984 8 : 323 333.
8. Beahrs OH. The American Joint Committee on Cancer. Bull Am Coll Surg 1984 69 : 16 7.
9. Srivastava A, Pandey SN, Choudhuri G, Mittal B. CCR5 Delta32 polymorphism: associated with gallbladder cancer susceptibility. Scand J Immunol 2008 67 : 516 522.
10. Srivastava A, Pandey SN, Choudhuri G, Mittal B. Role of genetic variant A-204C of cholesterol 7alpha-hydroxylase (CYP7A1) in susceptibility to gallbladder cancer. Mol Genet Metab 2008 94 : 83 9.
11. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucl Acids Res 1988 16 : 1215.
12. Xiang L, Rundles JR, Hamilton DR, Wilson JG. Quantitative alleles of CR1: coding sequence analysis and comparison of haplotypes in two ethnic groups. J Immunol 1999 163 : 4939 4945.
13. Schneider S, Roessli D, Excoffier L. Arlequin: a software for population genetics data analysis. User manual ver 2.0. Genetics and Biometry Lab, Department of Anthropology, University of Geneva 2000, 111 pp.
14. Wacholder S, Chanock S, Garcia-Closas M, El Ghormli L, Rothman N. Assessing the probability that a positive report is false: an approach for molecular epidemiology studies. J Natl Cancer Inst 2004 96 : 434 442.
15. Lazcano-Ponce EC, Miquel JF, Munoz N et al. Epidemiology and molecular pathology of gallbladder cancer. CA Cancer J Clin 2001 51 : 349 364.
16. Zimnoch L, Szynaka B, Kupisz A. Study on carcinogenesis in chronic cholecystitis. Rocz Akad Med Bialymst 2004 49 (Suppl 1 49 51.
17. Wang FS, Chu FL, Jin L et al. Acquired but reversible loss of erythrocyte complement receptor 1 (CR1, CD35) and its longitudinal alteration in patients with severe acute respiratory syndrome. Clin Exp Immunol 2005 139 : 112 119.
18. Tamano M, Ohi H, Sudo S, Tomino Y. Quantitative polymorphism of complement receptor type 1 (CR1) in patients undergoing haemodialysis. Nephrol Dial Transplant 2004 19 : 1467 1473.
19. Wilson JG, Murphy EE, Wong WW, Klickstein LB, Weis JH, Fearon DT. Identification of a restriction fragment length polymorphism by a CR1 cDNA that correlates with the number of CR1 on erythrocytes. J Exp Med 1986 164 : 50 9.
20. Kumar A, Malaviya AN, Sinha S, Khandekar PS, Banerjee K, Srivastava LM. C3b receptor (CR1) genomic polymorphism in rheumatoid arthritis. Low receptor levels on erythrocytes are an acquired phenomenon. Immunol Res 1994 13 : 61 71.
21. Kumar A, Sinha S, Khandekar PS, Banerjee K, Srivastava LM. Hind III genomic polymorphism of the C3b receptor (CR1) in patients with SLE: low erythrocyte CR1 expression is an acquired phenomenon. Immunol Cell Biol 1995 73 : 457 462.